Symbiotec Pharmalab receives EIR from USFDA for Pithampur facility with VAI status

Symbiotec Pharmalab Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 544889 | NSE: SYMBIOTEC

29 Sep 2026 Evaluate

Symbiotec Pharmalab has received the establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its manufacturing facility in Pithampur (SEZ), Madhya Pradesh India with a Voluntary Action Indicated (VAI) status. The inspection was conducted at the company’s manufacturing facility at Pithampur, from August 10, 2026 to August 14, 2026.

Symbiotec Pharmalab is a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms - organic chemistry, biotechnology and complex injectables.

Peers

Company Name	CMP
Sun Pharma. Inds.	1820.00
Dr. Reddys Labs.	1236.00
Cipla	1350.00
Lupin	2042.00
Zydus Lifesciences	1163.35
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.